PetMed Express (PETS) Q2 2025 earnings summary

Executive summary

• Net sales for Q2 FY2025 were $59.6 million, down 16.1% year-over-year, with gross margin rising to 29.1% and net income increasing to $2.3 million, driven by cost reductions and a tax benefit.

• Adjusted EBITDA for the quarter was $2.1 million, down 39% year-over-year but improved sequentially from a Q1 loss.

• Transformation initiatives, including operational consolidation of PetMeds and PetCareRx, have materially lowered the cost structure and improved profitability.

• Enhanced customer service, technology, and rebranding efforts, including a modernized website and improved customer ratings.

• The company continues to face macroeconomic headwinds, including inflation and changing consumer behavior.

Financial highlights

• Gross profit for Q2 FY2025 was $17.3 million, down from $20.1 million year-over-year, with gross margin improving to 29.1% from 28.3%.

• Operating expenses decreased to $16.8 million from $19.2 million in the prior year period, and general and administrative expenses dropped 12.3% to $10.5 million.

• Net income was $2.3 million ($0.11 per diluted share), up from $0.7 million ($0.03 per share) last year, aided by a $1.4 million tax benefit.

• Cash and cash equivalents stood at $52.0 million as of September 30, 2024, with no debt.

• Inventories decreased significantly to $13.1 million from $28.6 million at March 31, 2024.

Outlook and guidance

• Management expects macroeconomic pressures, including inflation and consumer cost sensitivity, to continue impacting revenue growth for the remainder of FY2025.

• Marketing investment will increase in Q3 and Q4 to drive new customer acquisition and re-engage lapsed customers.

• Expectation of lower gross margin in Q3 due to heavier promotional activity, consistent with historical trends.

• Plans to invest in differentiated product assortments, brand awareness, and core marketing initiatives to drive growth.

• The board suspended the quarterly dividend to prioritize growth and higher-return initiatives.